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Background: Systematic reviews are important for informing clinical practice and health policy. The aim of this
study was to examine the bibliometrics of systematic reviews and to determine the amount of variance in citations
predicted by the journal impact factor (JIF) alone and combined with several other characteristics.
Methods: We conducted a bibliometric analysis of 1,261 systematic reviews published in 2008 and the citations to
them in the Scopus database from 2008 to June 2012. Potential predictors of the citation impact of the reviews
were examined using descriptive, univariate and multiple regression analysis.
Results: The mean number of citations per review over four years was 26.5 (SD ±29.9) or 6.6 citations per
review per year. The mean JIF of the journals in which the reviews were published was 4.3 (SD ±4.2). We found
that 17% of the reviews accounted for 50% of the total citations and 1.6% of the reviews were not cited. The
number of authors was correlated with the number of citations (r = 0.215, P < 0.001). Higher numbers of citations
were associated with the following characteristics: first author from the United States (36.5 citations), an ICD-10
chapter heading of Neoplasms (31.8 citations), type of intervention classified as Investigation, Diagnostics or Screening
(34.7 citations) and having an international collaboration (32.1 citations). The JIF alone explained more than half
of the variation in citations (R2 = 0.59) in univariate analysis. Adjusting for both JIF and type of intervention increased
the R2 value to 0.81. Fourteen percent of reviews published in the top quartile of JIFs (≥ 5.16) received citations in the
bottom quartile (eight or fewer), whereas 9% of reviews published in the lowest JIF quartile (≤ 2.06) received
citations in the top quartile (34 or more). Six percent of reviews in journals with no JIF were also in the first
quartile of citations.
Conclusions: The JIF predicted over half of the variation in citations to the systematic reviews. However, the
distribution of citations was markedly skewed. Some reviews in journals with low JIFs were well-cited and others in
higher JIF journals received relatively few citations; hence the JIF did not accurately represent the number of citations
to individual systematic reviews.
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Systematic reviews can guide clinical practice and health
policy. The number of systematic reviews published in
the literature is increasing at a steady rate. It was estimated
that in 1990 there were approximately 250 published
systematic reviews on healthcare [1]. In August 2013,
the Cochrane Database of Systematic Reviews contained
5,637 reviews and 2,405 protocols, and the Database of
Abstracts of Reviews of Effectiveness (DARE) contained* Correspondence: p.l.royle@warwick.ac.uk
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for national bodies such as the National Institute for
Health and Care Excellence (NICE), the National Institute
for Health Research Health Technology Assessment
(NIHR HTA) Programme and other funders. Similarly,
in the United States, the Agency for Healthcare Research
& Quality (AHRQ) Technology Assessments Program
commissions reviews based on a systematic review of
the literature by a group of research teams in the
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decisions, and the increasing use of HTAs by policymakers
has been one of the drivers of the increasing number of
systematic reviews.
However, producers of systematic reviews in academic
institutions need to justify performing them in terms of
academic performance measures, such as publications and
citations. These measures are important when competing
for research funds and also for professional status and
career progression, as well as in the recruitment of new
staff. Performance is based partly on the number of
publications in peer-reviewed journals and partly on
the impact of those publications, as reflected in citation
rates. In addition, citation rates may be used by funders of
research as one indicator of the impact and dissemination
of research they have funded. Research-active institutions
will therefore wish to maximise citation rates to increase
their success in securing funding.Journal impact measures
The journal impact factor (JIF) is obtained from the
Journal Citation Reports (Thomson Reuters, New York,
NY, USA) and is a measure of journal prestige and impact
[2]. The impact factor is calculated by dividing the number
of citations in the year by the total number of articles
published in the two previous years. For example, the
2010 impact factor equals the number of citations in
2010 to items published in 2008 and 2009 divided by
the number of items published in 2008 and 2009. In
2007, the five-year JIF was introduced. It is similar in
nature to the two-year impact factor, but citations in a
given year are counted back to the previous five years
and divided by the number of source items published
in the previous five years. It was thought that a base of
five years might be more appropriate for journals in
certain fields, where the body of citations may not be
large enough to make reasonable comparisons, or that
it might take longer than two years to disseminate and
respond to published works.
Other journal metrics have come into use more
recently. The SCImago Journal & Country Rank (SJR)
uses a three-year citation window. The choice of three
years as the publication window (rather than two or
five years used for JIFs) is based on the observation that
citations in many fields have not peaked after two years
and citations in other fields have peaked too early for a
five year cut-off [3]. The SJR also differs from JIFs in
that not all citations are counted as being equal; that is, it
weights the citations received according to the prestige
of the citing journal [4]. Another journal metric is the
Source Normalized Impact per Paper, or SNIP. It measures
contextual citation impact by weighting citations on
the basis of the total number of citations in a subjectfield, hence correcting for differences in citation potential
and topicality between subject fields [3,5].
However, the most widely used and known of the
journal metrics is the two-year JIF. Journal editors strive
to improve their journal’s impact factor, as it is key to
the journal’s ability to attract the best papers and hence
to the survival of the journal [6-8].
Although it is intended to rate journals, the JIF of the
journal in which an article has been published is widely
used by academics and funding bodies as a surrogate
measure of the quality and impact of the article itself
[9-11], and some universities will instruct researchers to
publish only in journals with an impact factor above a
certain level [7]. However, as the distribution of citations
to individual articles in a journal is known to be skewed
and is often driven by a few highly cited articles, the JIF
does not accurately reflect citations to the average article
in the journal [12-15].
In some universities in the United Kingdom, JIFs will
act as an important determinant in the selection of
research papers (academic “outputs”) for the UK Research
Excellence Framework (REF) in 2014 [15]. There is a
common assumption that publication in journals with
high JIFs will be associated with higher numbers of
citations. Therefore, knowing how well JIFs, as well as
other factors, predict citations to systematic reviews may
be useful to those undertaking or planning systematic
reviews in academic institutions preparing for the REF or
similar academic assessment exercises in other countries
and could be useful for formulating a publications strategy
that will maximise the citation rates for systematic reviews.
Therefore, our primary aim was to undertake a biblio-
metric analysis of systematic reviews and to determine
how well the JIF, alone and in combination with several
other characteristics, predicts citations to systematic re-
views. Our secondary aim was to determine the character-
istics associated with systematic reviews that distinguish
those that are highly cited from those that receive few
or no citations.
Methods
Search strategy for systematic reviews
Terminology
Many, but not all, systematic reviews contain meta-ana-
lyses. In some cases, it is not possible or valid to perform a
meta-analysis of the included studies because of clinical,
methodological or statistical differences between studies
[16]. Therefore, we will use the term systematic reviews
collectively to refer to both systematic reviews that include
a meta-analysis and those that do not.
Searches of the Scopus database
We searched the Scopus database in June 2012 using
the following search strategy: “meta-analysis or systematic
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Review, publication year = 2008, Subject Areas = Life
Sciences or Health Sciences and Language = English
language. The Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) Statement rec-
ommends that all systematic reviews or meta-analyses
describe themselves with either or both of the words
meta-analysis and systematic review in the title [17]. This
search identified 1,381 articles and the bibliographic
details and number of citations to each review were
exported into Reference Manager.
Searches of the Cochrane Database of Systematic Reviews
We performed a separate search of the Cochrane Data-
base to identify Cochrane reviews to include in our data
set, as Cochrane reviews are not described as systematic
reviews in the title. Also, as they are regularly updated,
both earlier and later versions of the same review may
be cited; therefore, it was necessary to check each review
to determine whether it was the current version and first
published in 2008. We searched the Cochrane Library,
issue 6, of 12 June 2012, limiting the search to 2008, and
thus identified 152 reviews. The full text of each review
was downloaded, and the history section of the review
was checked to determine whether the review was first
published in 2008. Methodology reviews and reviews
that had been withdrawn were excluded. This led us to
identify 79 reviews which were new to the Cochrane
Database in 2008 that represented the current version.
We then searched for these reviews in Scopus, and we
downloaded the bibliographic details and number of
citations into Reference Manager and Microsoft Excel
(Microsoft, Redmond, WA, USA) for analysis.
The number of records gathered from both searches
in Reference Manager was 1,460, and the abstracts were
all screened for inclusion. To meet the inclusion criteria
on the basis of the abstract, the review had to appear to
have a clearly focused aim and an adequate search
strategy, and it had to report the inclusion criteria.
These criteria were based on those for the DARE data-
base [18]. The abstracts of each review were checked, and
we excluded articles that were not systematic reviews
or did not include human studies and those that were
methodological reviews or reviews of reviews. The full
text was obtained for 95 studies in which the eligibility
criteria could not be determined from the abstract. If
the article did not include the criteria mentioned above
or have a table of the characteristics of the included
studies, it was excluded. A further 199 records were
removed, which left 1,261 systematic reviews remaining
in the data set. Additional file 1: Figure S1 shows the
flow diagram for the searches.
The searches were performed in June 2012, so this gave
an average time of four years to accumulate citations (witha range from 3.5 to 4.5 years). We considered four years
to be enough time to accumulate sufficient citations to
show differences between reviews.
Obtaining data for the characteristics of the
systematic reviews
We collected data on the following variables for each
systematic review: (1) JIF; (2) JIF −5 years; (3) number of
pages of the review; (4) country location of the authors;
(5) number of authors; (6) international collaboration;
(7) condition or disease classified by the International
Statistical Classification of Diseases and Related Health
Problems, 10th Revision (ICD-10) [19], chapter code; and
(8) type of intervention (for example, drug, nonpharma-
cological treatment, investigation). Variables 1 and 2 are
characteristics of the journal in which the review was
published, and variables 3 to 8 are characteristics unique
to the article. Data on the number of citations, number
of authors, country location of authors and number of
pages per article were extracted from the information
exported from bibliographic data in the Scopus database.
Impact factors
The two-year and five-year JIFs for each journal title
were obtained manually from the Journal Citation Reports:
JCR Science Edition 2010 impact factors, published by
Thomson Reuters (hereinafter JIF will refer to the impact
factor measured over two years, and JIF-5 will refer to
the five-year impact factor).
SCImago Journal & Country Rank
The 2011 SJR data were downloaded into an Excel file
from the SCImago Journal & Country Rank website, which
gave a complete list of journal rankings [20]. These data
were imported into Microsoft Access and matched via
the journal titles field in our data set.
Number of pages
The number of pages of each article was obtained from
Scopus and was based on the start page and the end page
of each review. For reviews in which this information
was not given (such as in electronic journals), the review
was downloaded and the pages of the main article were
manually counted. This count did not include the pages
in the supplementary data or appendices available on-
line only.
ICD-10 chapter code
The coding of topics was carried out using the 22 codes
in ICD-10 version 2010 [19], plus an additional code =
99 for ‘Uncertain or not known’. Each abstract was read
by one author (NW) and classified into one of the 22
disease codes. These were checked by a second author
(PR), and any differences were resolved by discussion.
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The classification of each type of intervention was de-
vised by one author (NW). It comprised the following 12
intervention types: (1) drugs; (2) surgery (including opera-
tions, fixation of fractures by operation of immobilisation);
(3) health promotion; (4) investigations, diagnostics or
screening; (5) psychological therapies; (6) vaccines; (7)
alternative therapies (such as acupuncture, homeopathy,
herbal medicines); (8) dentistry (covering “operation” and
application of drugs such as fluoride gels or fissure seal-
ants); (9) not an intervention; (10) mixed (some reviews
cover all possible treatments, such as drugs, surgery and
acupuncture); (11) vitamins, food supplements, exclusion
diets and foods; and (12) Other.
As many systematic reviews are now on topics that are
not interventions, a category of “Not an intervention”
was necessary. Although systematic reviews have often
been associated with interventions, this is now changing,
as exemplified by the Cochrane Database, which initially
included only reviews of treatments but more recently
has included reviews of diagnostic methods.
Each review was classified by one author (NW) on the
basis of the abstract into one of the 12 intervention
types. These were checked by a second author (PR), and
any differences were resolved by discussion.
Country location of the authors and international
collaboration
The full institutional address of each author was exported
from the Scopus database into Excel files, and this was
used to determine the country location of the first author
and all coauthors. Any articles that included authors
with addresses from different countries were coded as
international collaborations.
Statistical analysis
Data were imported into SPSS version 20 software (SPSS,
Chicago, IL, USA) and Stata version 12 software (Stata
Corp, College Station, TX, USA) from Microsoft Excel
files. Descriptive analyses and Pearson correlations for
continuous variables were performed in SPSS and Stata.
In the univariate analysis for categorical variables, the
Kruskal-Wallis test was used in SPSS to test the statistical
significance of any differences in the categories with
respect to the non–normally distributed continuous
variable, citations.
The number of citations (the dependent variable) was
positively skewed; therefore, the natural log transform-
ation was obtained to approach a normal distribution.
As some reviews had zero citations, the number 1 was
first added to the number of citations to overcome the
problem of log transformation of zero values.
Some of the predictor (independent) categorical variables
(country location of first author, ICD-10 chapters andintervention type) had a large number of categories,
which resulted in small numbers in some categories.
Therefore, some categories were combined, and dummy
variables were created as reference categories for re-
gression analysis.
We present the R2 values, which represent the amount
of variance contributed by each variable in the different
models, to explain the citations in the results of the
multivariate linear regression model rather than pre-
senting the regression coefficients and associated 95%
confidence intervals of log-transformed citations. A P-
value ≤ 0.05 was considered statistically significant. All
multivariate analyses were conducted using Stata version
12 software.Results
Distribution of citations
The search of Scopus resulted in 1,261 systematic reviews
published in 2008. The number of citations varied from
zero to 221, and the reviews were published in 613 dif-
ferent journals. The four journal titles which accounted
for the highest number of reviews were the Cochrane
Database of Systematic Reviews (n = 79; 6.3%), Health
Technology Assessment (n = 21; 1.7%), Annals of Internal
Medicine (n = 18; 1.4%) and JAMA (n = 12; 1.0%). The
remaining reviews were widely scattered, and 379 journals
contained only one review.
The citations to the reviews were heavily skewed: 5.5%
of the top-cited reviews accounted for 25% of the total
citations, and 17% of the reviews accounted for 50% of
the total citations. Also, 50% of the reviews contributed
84% of the total citations. Twenty reviews (1.6%) were
not cited.
The characteristics of the 1,261 systematic reviews
are shown in Table 1. The mean number of citations per
review, accumulated after a mean of four years, was 26.5
(SD ±28.9). This equated to a mean of 6.6 citations per
review per year.
Eighty-seven percent of the reviews were published in
a journal with a JIF, and the mean JIF was 4.3 (SD ±4.2).
Also, 80.6% of the reviews were in journals with a five-
year JIF, and the mean JIF-5 was 4.6 (SD ±4.1).
The JIFs and the number of citations were both divided
into quartiles, and a comparison was made between the
top JIF quartile that had citation numbers in the bottom
quartile and vice versa. There were 1,101 reviews pub-
lished in journals with a JIF. We found that 14% (38 of
275) of reviews in the top JIF quartile (≥ 5.16) received
citations in the bottom quartile (≤ 8 citations), and 9%
(25 of 275) of reviews in the bottom JIF quartile (≤ 2.06)
received citations in the top quartile (≥ 34 citations).
Also, 6.3% (10 of 160) of reviews with no JIF had citation
numbers in the top quartile.
Table 1 Characteristics of systematic reviews (N = 1,261)
published in 2008a
Characteristics Data
Citations over a mean of four years, mean (±SD) 26.5 (28.9)
Two-year JIF, mean (±SD; n = 1,101) 4.3 (4.2)
Five-year JIF (mean ± SD; n = 1,016) 4.6 (4.1)
Number of authors, mean (±SD) 4.3 (2.7)
Number of pages, mean (±SD) 16.0 (25.6)
Country location of first author, n (%)
United Kingdom 301 (23.9)
United States 285 (22.6)
Canada 145 (11.5)
The Netherlands 83 (6.6)
Australia 83 (6.6)
All other countries 364 (28.9)
ICD-10 chapters, n (%)
Neoplasms 135 (10.7)
Diseases of the circulatory system 120 (9.5)
Factors influencing health status and contact
with health services
119 (9.4)
Mental and behavioural disorders 103 (8.2)
Diseases of the digestive system 103 (8.2)
All other ICD-10 codes 681 (54.0)
Intervention type, n (%)
Not an intervention 443 (35.1)
Drugs and vaccines 243 (19.3)
Surgery and dentistry 139 (11.0)
Investigations, diagnostics or screening 128 (10.2)
Health promotion 45 (3.6)
All other interventions 263 (20.9)
International collaboration, n (%)
No 1,057 (83.8)
Yes 204 (16.2)
aICD-10, International Statistical Classification of Diseases and Related Health
Problems, 10th Revision; JIF, journal impact factor.
Table 2 Correlation between continuous variables and
citations to systematic reviews
Characteristics Correlation with citations P-value
Journal impact factor (JIF) 0.453 0.000
Journal impact factor-5 (JIF-5) 0.444 0.000
SCImago Journal Rank (SJR) 0.438 0.000
Number of authors 0.215 0.000
Number of pages −0.002 0.943
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The mean number of authors per review was 4.3 (SD ±2.7),
and the mean number of pages per review was 16
(SD ±25.6), but the latter did not take into account
the pages in the supplementary data or appendices
available online only in some print journals.
As the categorical variables, country locations of first
author, ICD-10 chapters and intervention types all had a
large number of categories, some were combined to
derive sufficient numbers in each category. The numbers
in each category, before being combined, are given in
Additional File 2.
Table 1 shows that the United Kingdom had the highest
percentage (24%) of first authors, followed by the UnitedStates (23%) and Canada (12%). The ICD-10 chapter with
the highest number of reviews was ‘Neoplasms’ (10.7%),
followed by ‘Diseases of the circulatory system’ (9.5%)
and ‘Factors influencing health status and contact with
health services’ (9.4%).
Examination of the intervention types shows that the
highest percentage (35%) of the reviews was in the
category ‘Not an intervention’. These reviews were on
a very wide range of topics. The commonest were epi-
demiological reviews, such as the incidence or cause of
diseases (for example, the role of risk factors in cardiovas-
cular disease). These were followed by reviews of factors
affecting use of healthcare (for example, ethnic variations
in uptake), reviews of outcomes of care (for example,
trends over time in survival) and economic reviews
including quality-of-life results and ‘burden of disease’.
The next most common type of intervention reviews
was in the category ‘Drugs and vaccines’ (19%). Sixteen
percent of reviews were international collaborations,
and all authors had addresses within the same country
in the remaining eighty-four percent.
Continuous variables and citations
Table 2 explores the correlation between citations and
the five continuous variables measured.
Four of the variables (JIF, JIF-5, SJR and number of au-
thors) were highly correlated (P < 0.000) with the number
of citations. The highest correlation (0.453) was with the
JIF. The number of pages was not significantly associated
with the number of citations (P = 0.943).
Categorical variables
Table 3 shows the mean number of citations accumulated
over four years for the categorical variables after com-
bining some categories with low numbers of citations.
The mean number of citations for all variables in each
category, prior to combining categories, is given in
Additional File 2.
Country location of first author
There was a significant difference in the mean number
of citations between the country locations of the first
authors (P < 0.000). The highest (36.5) was for reviews
Table 3 Categorical variables predicting citations to
systematic reviews (mean number of citations and
adjusted odds ratios)a
Variables Mean number of
citations (±SD)
P-value
Country location of first author
United States 36.5 (37.4) 0.000
The Netherlands 29.0 (34.3)
Canada 24.4 (24.6)
United Kingdom 23.8 (25.9)
Australia 23.0 (19.5)
All other countries (reference category) 22.1 (23.4)
ICD-10 chapters
Neoplasms 31.8 (30.9) 0.000
Mental and behavioural disorders 29.5 (27.7)
Diseases of the circulatory system 29.1 (31.5)
Factors influencing health status and
contact with health services
26.0 (31.1)
Diseases of the digestive system 17.0 (18.7)




Investigations, diagnostics or screening 34.7 (34.8) 0.009
Drugs and vaccines 27.8 (30.4)
Not an intervention 26.9 (29.2)
Health promotion 25.2 (25.3)
Surgery and dentistry 21.7 (22.2)
Other treatments (reference category) 23.6 (26.8)
International collaboration
Yes 32.1 (34.3) 0.000
No (reference category) 25.5 (27.6)
aICD-10, International Statistical Classification of Diseases and Related Health
Problems, 10th Revision.
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Netherlands (29.0).Table 4 R2 values after adjustment in multiple
regression analysisa
Factors adjusted for in multiple regression R2 values
Journal impact factor 0.592
Journal impact factor and intervention type 0.806
Journal impact factor and country location of first author 0.763ICD-10 chapters
A significant difference (P < 0.000) was found in the mean
number of citations to reviews with respect to the ICD-10
chapter codes. The highest mean number of citations
(31.8) was for the chapter heading ‘Neoplasms’. This
was followed by ‘Mental and behavioural disorders’ and
‘Diseases of the circulatory system’, with means of 29.5
and 29.1 citations, respectively.Journal impact factor and number of authors 0.759
Journal impact factor and ICD-10 code 0.692
Journal impact factor and international collaboration 0.619
aICD-10, International Statistical Classification of Diseases and Related Health
Problems, 10th Revision.Type of intervention
There was a significant difference (P = 0.009) in the mean
number of citations between the different types of inter-
ventions. The intervention type with the highest meannumber of citations (34.7) was ‘Investigations, diagnostics
or screening’, followed by ‘Drugs and vaccines’ (27.8).
International collaboration
The mean number of citations to reviews which had au-
thors from more than one country (32.1) was significantly
higher (P = 0.000) than for those where all authors were
from the same country (25.5).
Regression analysis
We performed multiple regression to determine the
amount of variation in citations explained by the JIF
and the additional amount explained by each of the five
variables added to JIF. The results given in Table 4
show that the JIF R2 = 0.592; that is, the JIF alone
accounted for 59.2% of the variation in citations of
reviews. The variable, which, when added to the JIF,
explained the most variation was the intervention type,
which explained an additional 21.4%. The additional
variations explained individually by each of the other
factors were country location of first author (17.1%),
number of authors (16.7%), ICD-10 code (10%) and
international collaboration (2.7%).
Characteristics of the journals with the top and bottom
50 number of citations
We compared reviews that had the top 50 and bottom
50 numbers of citations. The 50 most-cited reviews were
spread over 32 different journals. The number of citations
ranged from 92 to 221. The Annals of Internal Medicine
had eight reviews, JAMA had six reviews and six other
journals contained two reviews each. The remaining 24
journals contributed just one review each. The Cochrane
Database of Systematic Reviews and Health Technology
Assessment, the publishers of the most reviews in this
study, contained one and zero reviews, respectively, that
were in the top 50 cited. The 50 least-cited reviews were
spread over 45 different journals. The number of citations
ranged from zero to two. Three reviews were from the
Cochrane Database of Systematic Reviews.
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and the 50 least-cited systematic reviews. There is a
statistically significant difference in the mean number of
citations, JIFs and number of authors, and in the percent-
ages of international collaboration, reviews published
in journals indexed in MEDLINE and journals with a
JIF. There was no statistically significant difference with
regard to the number of pages of the review.
The most common ICD-10 chapter in the top 50 was
‘Neoplasms’, and ‘Diseases of the respiratory system’ was
the most common in the bottom 50. The most common
country location of first authors in the top 50 was the
United States, and the United Kingdom was most the
common first-author country location in the bottom
50 cited.Discussion
In this study, we examined several characteristics of
systematic reviews and citations to them four years
after publication. The citations to the reviews were
heavily skewed, with 17% of the reviews accounting for
50% of the total citations. Also, 14% of reviews that
were published in journals in the top quartile of JIFs
received citations in the bottom quartile, 9% of reviews
published in journals in the lowest JIF quartile received
citations in the top quartile and 6% of reviews in
journals with no JIF were also in the top quartile of
citations.
The univariate analysis showed that adjusting for JIF
alone showed it predicted 59% of the citations. When
the data were adjusted for both the JIF and type of
intervention, the R2 value increased to 0.81, so these two
factors explained 81% of the variance in the citations.
An examination of the top 50 versus bottom 50 reviews
cited showed that the journals Annals of Internal Medicine
and JAMA contained the highest number of highly cited
reviews. The Cochrane Database of Systematic ReviewsTable 5 Comparison of the 50 most-cited versus 50 least-cited
Characteristics Top 50 cited
Number of citations (mean) 132.0 (SD ±29.7)
JIF (mean) 10.5 (SD ±8.89)
Number of authors (mean) 6.3 (SD ±6.4)
Number of pages (mean) 12.5 (SD ±9.4)
International collaboration 24%
Published in journals with JIF 100%
Indexed in MEDLINE 100%
Top ICD-10 chapter 16% ‘Neoplasms’
Top intervention type 40% ‘Not an intervention’
Top country location of first author 48% United States
aICD-10, International Statistical Classification of Diseases and Related Health Problempublished only one review in the top 50, despite being
the journal with the most reviews in the total data set.
Strengths and limitations of this study
The main strengths of this study are that it is the first to
look at predictors of citations specifically to systematic
reviews published over a wide range of subject areas and
journals, and it included a number of characteristics of
both the article itself and the journal in which it appeared.
Possible limitations included the fact that not all sys-
tematic reviews would be captured in our search. We
restricted our search to the English-language literature
and to reviews with the words systematic review or meta-
analysis in the title (as recommended in the PRISMA
statement). Therefore, it is possible that such reviews are
of higher quality and hence receive more citations than
other systematic reviews.
Other studies and models used to predict citations to
articles in medical journals
Other studies have looked at predictors of citations to
articles in medical journals. Lokker and colleagues in-
vestigated whether citation counts at two years could
be predicted for clinical articles that pass basic critical
appraisal criteria data available within three weeks of
publication [21]. They collected 20 variables for each
article, and included 1,261 articles published in 105
journals. Cochrane reviews and articles from the HTA
database accounted for 24% of the sample. Their results
showed that the regression equation accounted for 60%
of the variation in citations (R2 = 0.60, 95% CI = 0.54 to
0.63; P < 0.001). Eleven variables remained statistically
significant in their regression model. However, most of
the variables collected in their study differed from those
in this study (except for number of pages and number of
authors) and did not include the JIF. Also, they included
only articles that met specific quality criteria and did
not limit articles to systematic reviews only.reviewsa
Bottom 50 cited P-value of difference
0.6 (SD ±0.5) <0.000
2.3 (SD ±2.3) <0.000
3.5 (SD ±2.2) 0.004




20% ‘Diseases of the respiratory system’
28% ‘Not an intervention’
34% United Kingdom
s, 10th Revision; JIF, journal impact factor.
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associated with higher citation rates in original articles,
regardless of study methodology, published in three
general medicine journals with high impact factors
[22]. They extracted data on nine variables from three
hundred twenty-eight articles and analysed them for their
association with the annual rate of citations per article
five years after publication. The following variables were
retained in a multivariable regression model: industry
funding, industry-favouring result, clinical category of
article, group authorship, journal of publication and
sample size. The model explained approximately 20%
of the variance (adjusted R2 = 0.20) in annual citation
rates of the cohort of articles. As the authors mentioned,
however, these results are not generalizable to articles
published in periodicals other than the three high-impact
general medical journals they reviewed. In contrast to
our present study, Kulkarni and colleagues included all
original articles of any methodology and did not adjust
for JIF in their model.
Callaham and colleagues identified characteristics pre-
dicting citations for a standardized 3.5 years after publi-
cation to 204 published articles originally submitted as
abstracts to a 1991 emergency medicine meeting [23].
The ability to predict the citations per year was weak
(pseudo-R2 = 0.14). Of the 11 variables included in the
regression model, the strongest predictor of citations
was the JIF of the publishing journal. After adjustment for
the JIF, the presence of a control group, the subjective
newsworthiness score and the sample size were the next
most important determinants of citation. They found
no relationship between study design (and other measures
of quality) and JIF. Although Callaham and colleagues
included JIF as a predictor variable, they did not include
any other variables similar to those included in our
present study. Also, in their study, they looked only at
research in one subject area and arising from only one
specialty meeting, and they included all study designs.
Distribution of citations
In this study, we found that just 17% of the reviews
accumulated 50% of the total citations and that 14% of
reviews in the journals with the higher JIFs were in the
bottom quartile of citations. Conversely, 15% of reviews
in the bottom JIF quartile or with no JIF were in the top
quartile of citations. This skewed distribution of citations
to systematic reviews is consistent with that reported in
other studies in medical journals [13,14,24]. Falagas
and colleagues looked at the distribution of citations in
clinical medicine journals for original research articles
and review articles in high-, moderate- and low-impact
journals and found that 12% to 18% of review articles
accounted for 50% of the citations, and this percentage
did not vary markedly between journals of different JIFlevels [14]. Therefore, articles published in a low-JIF
journal can still be oft-cited, and, conversely, articles
appearing in high-JIF journals can receive few or no
citations.
Length of reviews and citations
Lokker and colleagues found a statistically significant
negative association between citation count and article
length, but this association disappeared when Cochrane
reviews and HTA reports were removed from the analysis
[21]. A positive relationship between article length and
citation count was reported by Falagas and colleagues,
but they looked at articles in only five general medical
journals, with a maximum length of 15 pages and with
reviews excluded [14].
We originally expected that longer reviews might be
wider in scope, more complex and of higher methodo-
logical quality (owing to more included studies, detailed
reporting of the quality assessment and study character-
istics, more sensitivity analyses in the results and a more
thorough discussion) and hence might receive more cita-
tions. However, we found that the length of reviews was
not significantly associated with the number of citations.
We hypothesise that the relationship between citation
count and number of pages may be different in system-
atic reviews. Some HTA reports and Cochrane reviews
in this study were over 200 pages long and contained
long Methods sections and data extraction tables, which
many readers may skip over. Such length might deter
people from printing, reading and citing them, as many
people still prefer to print out articles rather than read
them on their screens.
Higher citation rates of systematic reviews
Our study seems to confirm the view that study designs
with higher methodological rigour, such as systematic
reviews and meta-analyses, have a higher citation rate
than other study designs [25-31]. The systematic reviews
included in this study had a mean of 26.5 citations over
four years, which gave a mean of 6.6 citations per review
per year, whereas the mean two-year and five-year JIFs
of the journals in which they were published were 4.3
and 4.6, respectively. These data indicate that, overall,
systematic reviews perform above average for the journals
in which they appear and therefore may increase the
JIFs of the journals in which they are published.
Uncitedness
In this study, we found that only 20 reviews (1.6%)
remained uncited after four years. The lower rates of
noncitation of reviews was also found by Weale and col-
leagues, who looked at total citations gained by October
2003 for every original article and review published in
immunology and surgery during 2001 [24]. Of the 30,208
Royle et al. Systematic Reviews 2013, 2:74 Page 9 of 11
http://www.systematicreviewsjournal.com/content/2/1/74articles, 24.3% were uncited by October 2003. The level
of noncitation was significantly lower for reviews (14.8%)
than for original articles (24.9%) (P < 0.0001).
Impact of number of authors and international collaboration
We observed that both international collaboration and
the number of authors improve citations. This could be
explained by the fact that having international collabor-
ation and a large number of authors may reflect the
complexity of the topic and hence the range of skills
required to do the review and perhaps the importance
of the topic. Figg and colleagues also observed that
the number of times an article is cited is significantly
and positively related to the number of authors and
institutions [32].
We speculate that another explanation for the associ-
ation of higher citations with number of authors and
international collaboration may be information gain. This
was described by Evangelou and colleagues, who found
that reviews that substantially reduce uncertainty may
be particularly highly cited [33]. They looked at the
correlation between the information gain from random-
ized trials and their publication in high-JIF journals and
quantified how much the new findings changed estab-
lished knowledge. They found that publication in journals
with high JIFs is driven by how extensively the results
of a study change prior perceptions of the evidence, in-
dependently of the statistical significance of the results
and the size of the trial and extent of heterogeneity of
the meta-analysis results.
Influence of subject area and type of intervention on
citations
The ICD-10 code ‘Neoplasms’ had the highest mean
number of citations in our present study. Kulkarni and
colleagues analysed features associated with higher cit-
ation rates in original articles published in four high-JIF
general medicine journals, regardless of study method-
ology [22]. In their adjusted analysis, higher annual rates
of citation were also associated with articles dealing with
cardiovascular medicine (13.3 more) and oncology (12.6
more).
The higher citations of reviews of the intervention types
classified as ‘Investigations, diagnostics or screening’
may reflect the need, in a time of limited resources, to
look critically at interventions other than drugs, especially
because many drugs have already been reviewed. Indeed,
studies of some drugs may have been reviewed several
times. Siontis and colleagues recently reported that over-
lapping meta-analyses on the same topic were common,
and all of their examples of “multiple meta-analyses” were
on medication-related topics [34]. Higher citations to
diagnostics reviews may also reflect the development in
the methods used for evaluating diagnostic technologies,such as in the Cochrane Collaboration. In the United
Kingdom, NICE, best known for issuing guidance
on new drugs, has started a diagnostics assessment
programme.Why are Cochrane reviews not more frequently cited?
We observed that only one review from the Cochrane
Database of Systematic Reviews was in the top 50 cited,
but three were in the bottom 50. This was surprising,
given that free or funded free access to the Cochrane
Library is widely available in many countries (but not in
North America), and Cochrane reviews have been shown
to be of higher quality than other reviews [35,36]. A
study by McKinlay and colleagues, however, showed that
even when access was provided equally to Cochrane and
journal reviews, the former were less popular [37]. Some
criticisms that have been levelled at Cochrane reviews
that may explain this fact are that there are too many
empty reviews (reviews in which only one or no random-
ised controlled trial are found), they lack relevance to
clinical practice because of the very narrow focus of the
questions, their length and complexity make them difficult
to read and extract the key clinical messages, and they
often lack a clear answer as to which treatment was better
[38-41]. Also, as one of our referees suggested, another
reason for low citations to some Cochrane reviews may
be that the choice of topic is made by the reviewers
and that the topics chosen may not be regarded as high
priority by clinicians in that specialty.Unanswered questions and future research
There are other characteristics of systematic reviews not
included in our model, which may also be predictors of
citation rates, such as the quality of the review, whether
the review included a meta-analysis, the number of studies
included, the study design of the included articles, whether
the review was positive or negative, whether the review
included an economic evaluation, the number of existing
reviews already done on the topic and the perceived infor-
mation gain.
It would be interesting to investigate whether open
access publications versus publication in a subscription-
only journal increases citations. Because of the variety in
open access provision (some journals are immediately
open access, other journals allow open access to some
articles and others allow delayed open access after
an embargo period), however, it would be difficult to
determine the access status of the review at the time of
citation. Also of interest would be a study that investi-
gates the difference in citation rates between reviews
published in dedicated review journals and more gen-
eral journals.
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Although JIFs were found to predict over half of the
citations of the systematic reviews, the distribution of
citations to them was markedly skewed. Some of the most
highly cited reviews were in journals with the lowest JIFs,
and some reviews in high JIF journals were poorly cited.
Hence the JIF is not an appropriate surrogate measure
of the impact of individual systematic reviews.
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